Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
Frontiers in Neurology|June 22, 2026
Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a post hoc analysis from a phase 3 migraine prevention studyChristian Lampl, Richard B Lipton, Sarah Lipsius, et al.
Headache|November 2, 2022
The unique role of stigma in migraine-related disability and quality of lifeElizabeth K Seng, Robert E Shapiro, Dawn C Buse, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) StudyDaniel Serrano, Aubrey N Manack, Michael L Reed, et al.
Neurology|August 5, 2020
Effect of fremanezumab on quality of life and productivity in patients with chronic migraineRichard B Lipton, Joshua M Cohen, Sanjay K Gandhi, et al.
Headache|September 3, 2013
Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) studyRichard B Lipton, Daniel Serrano, Robert A Nicholson, et al.
Journal of Managed Care & Specialty Pharmacy|July 18, 2020
Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for MigraineDawn C Buse, Marianna S Yugrakh, Lulu K Lee, et al.
Clinical Neurology and Neurosurgery|November 17, 2022
Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) StudyAli Ezzati, Dawn C Buse, Kristina M Fanning, et al.
Cephalalgia : an International Journal of Headache|August 18, 2021
What do people want to know about "Growing Up with Migraine"? Results of a preference survey of people with lived experience to guide future researchJames S McGinley, Andrea Savord, Carrie R Houts, et al.
Headache|May 6, 2024
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I studyDawn C Buse, Fumihiko Sakai, Manjit Matharu, et al.
Headache|June 13, 2017
Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.
Pageof 23